Literature DB >> 11067927

Vesicular localization and characterization of a novel post-proline-cleaving aminodipeptidase, quiescent cell proline dipeptidase.

M Chiravuri1, F Agarraberes, S L Mathieu, H Lee, B T Huber.   

Abstract

A large number of chemokines, cytokines, and signal peptides share a highly conserved X-Pro motif on the N-terminus. The cleavage of this N-terminal X-Pro dipeptide results in functional alterations of chemokines such as RANTES, stroma-derived factor-1, and macrophage-derived chemokine. Until recently, CD26/DPPIV was the only known protease with the ability to cleave N-terminal X-Pro motifs at neutral pH. We have isolated and cloned a novel serine protease, quiescent cell proline dipeptidase (QPP), with substrate specificity similar to that of CD26/DPPIV. In this paper we show that QPP, like CD26/DPPIV, is synthesized with a propeptide and undergoes N:-glycosylation. Interestingly, this glycosylation is required for QPP enzymatic activity, but not for its localization. Unlike the cell surface molecule, CD26/DPPIV, QPP is targeted to intracellular vesicles that are distinct from lysosomes. Proteinase K treatment of intact vesicles indicates that QPP is located within the vesicles. These vesicles appear to have a secretory component, as QPP is secreted in a functionally active form in response to calcium release. The presence of QPP in the vesicular compartment suggests that molecules bearing the N-terminal X-Pro motif can be cleaved at multiple sites within and outside the cell. These results expand the potential site(s) and scope of a process that appears to be an important mechanism of post-translational regulation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11067927     DOI: 10.4049/jimmunol.165.10.5695

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

Review 1.  The metabolic serine hydrolases and their functions in mammalian physiology and disease.

Authors:  Jonathan Z Long; Benjamin F Cravatt
Journal:  Chem Rev       Date:  2011-06-23       Impact factor: 60.622

2.  Multicohort analysis reveals baseline transcriptional predictors of influenza vaccination responses.

Authors: 
Journal:  Sci Immunol       Date:  2017-08-25

3.  Synthesis and activity of a potent, specific azabicyclo[3.3.0]-octane-based DPP II inhibitor.

Authors:  Olga Danilova; Bei Li; A Katrin Szardenings; Brigitte T Huber; Jonathan S Rosenblum
Journal:  Bioorg Med Chem Lett       Date:  2006-10-10       Impact factor: 2.823

4.  Identification of three immunologic correlates for HIV type 1 pathogenesis in youth.

Authors:  Wei Song; Yufeng Li; Craig M Wilson; Jianming Tang
Journal:  AIDS Res Hum Retroviruses       Date:  2010-12-13       Impact factor: 2.205

5.  Cloning and characterization of dipeptidyl peptidase 10, a new member of an emerging subgroup of serine proteases.

Authors:  Shu Y Qi; Pierre J Riviere; Jerzy Trojnar; Jean-Louis Junien; Karen O Akinsanya
Journal:  Biochem J       Date:  2003-07-01       Impact factor: 3.857

6.  Th17 differentiation is the default program for DPP2-deficient T-cell differentiation.

Authors:  Deanna A Mele; James F Sampson; Brigitte T Huber
Journal:  Eur J Immunol       Date:  2011-05-13       Impact factor: 5.532

7.  Kinetic investigation of human dipeptidyl peptidase II (DPPII)-mediated hydrolysis of dipeptide derivatives and its identification as quiescent cell proline dipeptidase (QPP)/dipeptidyl peptidase 7 (DPP7).

Authors:  Marie-Berthe Maes; Anne-Marie Lambeir; Kambiz Gilany; Kristel Senten; Pieter Van der Veken; Barbara Leiting; Koen Augustyns; Simon Scharpé; Ingrid De Meester
Journal:  Biochem J       Date:  2005-03-01       Impact factor: 3.857

8.  Sphingosine kinase 1 isoform-specific interactions in breast cancer.

Authors:  Daniel Yagoub; Marc R Wilkins; Angelina J Lay; Dominik C Kaczorowski; Diana Hatoum; Sarah Bajan; Gyorgy Hutvagner; Jack H Lai; Wengen Wu; Rosetta Martiniello-Wilks; Pu Xia; Eileen M McGowan
Journal:  Mol Endocrinol       Date:  2014-09-12

9.  Neurogenin 3-specific dipeptidyl peptidase-2 deficiency causes impaired glucose tolerance, insulin resistance, and visceral obesity.

Authors:  Olga V Danilova; Albert K Tai; Deanna A Mele; Martin Beinborn; Andrew B Leiter; Andrew S Greenberg; James W Perfield; Jason Defuria; Praful S Singru; Ronald M Lechan; Brigitte T Huber
Journal:  Endocrinology       Date:  2009-10-09       Impact factor: 4.736

10.  Catalytic properties and inhibition of proline-specific dipeptidyl peptidases II, IV and VII.

Authors:  Barbara Leiting; KellyAnn D Pryor; Joseph K Wu; Frank Marsilio; Reshma A Patel; Charles S Craik; Jonathan A Ellman; Richard T Cummings; Nancy A Thornberry
Journal:  Biochem J       Date:  2003-04-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.